Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Licenses Probe Technology to Quest

NEW YORK (GenomeWeb News) – Nanogen has licensed its minor groove binder probe technology to Quest Diagnostics for use in human in vitro diagnostics tests.

Clinical lab firm Quest will pay Nanogen an undisclosed upfront fee and royalties based on sales of products that incorporate the MGB Probe technology.

Nanogen noted that licensing deals for the MGB Probe technology now represents the majority of Nanogen's revenues. It said that it has more than 40 reagent and kit products sold for IVD use usnder the MGB Alert and Q-PCR Alert brands.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more